Stem cells

A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe ARDS From COVID-19

RATIONALE: There are limited therapeutic options for patients with COVID-19-related acute respiratory distress syndrome (ARDS) with inflammation-mediated lung injury. Mesenchymal stromal cells offer promise as immunomodulatory agents. OBJECTIVES: …